Grant Publications
Proposal No. IBD-0276R
Principal Investigator: Biju Parekkadan, Ph.D.
Applicant Organization: Massachusetts General Hospital (Charlestown, U.S.A.)
Project Title: Antigen-specific mesenchymal stem cell grafts for inflammatory bowel disease
Period of Award: January 1, 2010 – February 29, 2012
Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering 2010;12:87-117.
Yagi H, Soto-Guiterrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan, Yarmush ML. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Molecular Therapy 2010;18:1857-64.
Jiao J, Milwid JM, Yarmush ML, Parekkadan B. A mesenchymal stem cell potency assay. Methods in Molecular Biology 2011;677:221-31.
Parekkadan B, Upadhyay R, Dunham J, Iwamoto Y, Mizoguchi E, Mizoguchi A, Weissleder R, Yarmush ML. Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes. Gastroenterology 2011 Mar;140:966-75.
Period of Award: January 1, 2010 – February 29, 2012
Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering 2010;12:87-117.
Yagi H, Soto-Guiterrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan, Yarmush ML. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Molecular Therapy 2010;18:1857-64.
Jiao J, Milwid JM, Yarmush ML, Parekkadan B. A mesenchymal stem cell potency assay. Methods in Molecular Biology 2011;677:221-31.
Parekkadan B, Upadhyay R, Dunham J, Iwamoto Y, Mizoguchi E, Mizoguchi A, Weissleder R, Yarmush ML. Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes. Gastroenterology 2011 Mar;140:966-75.